Atossa Genetics (ATOS) Misses Q2 EPS by 2c

Atossa Genetics (NASDAQ: ATOS) reported Q2 EPS of ($0.08), $0.02 worse than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Atossa Genetics (ATOS) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Corpay agrees to $100M FTC settlement over marketing practices
• Wells Fargo cuts Netflix rating on engagement risk, weak slate